Transaction · 0001814189-26-000007

Kerr Douglas

Kerr Douglas, HR, DC, reported a transaction classified as grant at Dyne Therapeutics, Inc. involving 12000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 12000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code AHR, DC
DYNDyne Therapeutics, Inc.
Trade date
Oct 20, 2026
Filing date
Oct 22, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded12.0k$0.00 per share
Holdings after12.0kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

DYN price since this filing

Daily closing prices, with the filing date and available return windows
DYN · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +6.5%1w ago -4.8%1d ago -5.2%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001814189-26-000007
Stock option (right to buy)
Transaction date
Oct 20, 2026
Filed Oct 22, 2026, 08:10 PM · 2d delay
Shares
12,000 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
12,000 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score

-6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Head of R&D and CMO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Consists of shares of Common Stock issuable under 8,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to ve…

  2. F2

    Includes 133,126 unvested RSUs.

  3. F3

    This option was granted on October 20, 2026. The shares underlying the option are scheduled to vest over four years in equal monthly installments through October 20, 2030.

Original filing · 0001814189-26-000007
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

DYN